Q2 2023 Holdings
Filed 2023-08-14 | 101 holdings | $4.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $843.0M | 19,991,024 | 18.0% |
| Glaukos Corp | NOTE 2.750% 6/1 | 377322AB8 | $412.7M | $271,452,000 | 8.8% |
| Viatris Inc(VTRS) | COM | 92556V106 | $176.7M | 17,703,484 | 3.8% |
| Amedisys Inc(AMED) | COM | 023436108 | $164.0M | 1,794,000 | 3.5% |
| Natera Inc | NOTE 2.250% 5/0 | 632307AB0 | $146.9M | $101,042,000 | 3.1% |
| Adapthealth Corp(AHCO) | COMMON STOCK | 00653Q102 | $135.0M | 11,094,914 | 2.9% |
| Ionis Pharmaceuticals Inc | NOTE 4/0 | 462222AD2 | $121.0M | $127,800,000 | 2.6% |
| Tabula Rasa Healthcare Inc | NOTE 1.750% 2/1 | 873379AA9 | $120.0M | $144,516,000 | 2.6% |
| Brookdale SR Living Inc | NOTE 2.000%10/1 | 112463AC8 | $114.8M | $145,955,000 | 2.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $114.1M | 1,209,714 | 2.4% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $110.1M | 8,192,000 | 2.4% |
| Accolade Inc | NOTE 0.500% 4/0 | 00437EAB8 | $102.1M | $122,598,000 | 2.2% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $98.2M | $103,200,000 | 2.1% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $94.4M | 6,707,026 | 2.0% |
| Intercept Pharmaceuticals in | NOTE 3.500% 2/1 | 45845PAC2 | $94.0M | $98,354,000 | 2.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $91.0M | 1,349,000 | 1.9% |
| Owens & Minor Inc New(ACH) | COM | 690732102 | $90.3M | 4,745,000 | 1.9% |
| Merus N V | COM | N5749R100 | $79.8M | 3,031,938 | 1.7% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $74.2M | 11,077,927 | 1.6% |
| Guardant Health Inc | NOTE 11/1 | 40131MAB5 | $63.9M | $89,036,000 | 1.4% |
| Hillevax Inc | COM | 43157M102 | $57.2M | 3,329,231 | 1.2% |
| Enhabit Inc(EHAB) | COM | 29332G102 | $55.3M | 4,809,803 | 1.2% |
| Nanostring Technologies Inc | NOTE 2.625% 3/0 | 63009RAD1 | $54.8M | $70,204,000 | 1.2% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $53.5M | 12,679,651 | 1.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $53.3M | 2,268,628 | 1.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $53.0M | 16,941,357 | 1.1% |
| Caremax Inc | COM CL A | 14171W103 | $49.3M | 15,861,090 | 1.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $46.9M | 1,751,496 | 1.0% |
| Livongo Health Inc | NOTE 0.875% 6/0 | 539183AA1 | $45.2M | $50,000,000 | 1.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $44.9M | 1,253,999 | 1.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $41.4M | 1,579,349 | 0.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $39.9M | 3,366,345 | 0.9% |
| Silk RD MED Inc | COM | 82710M100 | $36.8M | 1,132,229 | 0.8% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $34.3M | 3,238,000 | 0.7% |
| PTC Therapeutics Inc | NOTE 1.500% 9/1 | 69366JAD3 | $33.0M | $32,000,000 | 0.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $30.5M | 3,933,137 | 0.7% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $30.2M | 2,340,118 | 0.6% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $30.1M | 2,535,723 | 0.6% |
| Docgo Inc(DCGO) | COM | 256086109 | $28.7M | 3,059,000 | 0.6% |
| Health Catalyst Inc | NOTE 2.500% 4/1 | 42225TAB3 | $28.6M | $30,000,000 | 0.6% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $28.5M | 313,289 | 0.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $26.1M | 627,813 | 0.6% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $23.0M | 2,077,893 | 0.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $22.7M | 1,050,198 | 0.5% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $22.0M | 870,000 | 0.5% |
| Xeris Biopharma Holdings Inc | NOTE 5.000% 7/1 | 98422LAA5 | $21.4M | $18,000,000 | 0.5% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $21.4M | 1,189,648 | 0.5% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $20.2M | 617,000 | 0.4% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $19.3M | 2,052,010 | 0.4% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $19.1M | 430,000 | 0.4% |